Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre((R)) YeastOne((R)) for Candida albicans: a prospective observational cohort study
SJ van Hal, SC-A Chen, TC Sorrell, DH Ellis, M Slavin, DM Marriott
Journal of Antimicrobial Chemotherapy | OXFORD UNIV PRESS | Published : 2014
Awarded by National Health Medical Research Council of Australia
The study was supported by an educational grant from Pfizer Inc. T. C. S. is a Sydney Medical Foundation Fellow, whose work was supported by the National Health Medical Research Council of Australia (grant number 264625).